InMed Pharmaceuticals Inc.
USD1.59
+0.07 (+4.61%)
CEO
Eric A. Adams Chem.
IPO Date
2014-05-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$1.50
Prev. Close
$1.52
Day Low
$1.50
Day High
$1.60
52W Low
$0.57
52W High
$5.50
Market Cap
$0.00B
Volume
0.09M
| 200,000 |
| $1.56 |
| 21 May 2026 | ADAR1 Capital Management, LLC | 10 percent owner | P-Purchase | Acquired | 200,000 | $1.50 |
| 21 May 2026 | ADAR1 Capital Management, LLC | 10 percent owner | Disposed | 0 | $0.00 |
| 19 Dec 2025 | Johnson Shane Aaron | Sr VP & General Manager | A-Award | Acquired | 8,500 | $1.29 |
| 19 Dec 2025 | Lemerond Nicole | director | A-Award | Acquired | 1,750 | $1.29 |
| 19 Dec 2025 | Klompas Neil A | director | A-Award | Acquired | 1,750 | $1.29 |
| 19 Dec 2025 | Jagpal Netta | Chief Financial Officer | A-Award | Acquired | 18,000 | $1.29 |
| 19 Dec 2025 | WOUDENBERG MICHAEL | Chief Operating Officer | A-Award | Acquired | 18,000 | $1.29 |
| 19 Dec 2025 | Bathery John Steven | director | A-Award | Acquired | 1,750 | $1.29 |